Yiwei Jiaohuang Ointment for Gastrointestinal Bleeding Associated With Oral Antithrombotic Agents

Inclusion Criteria: * Oral therapy with at least one antiplatelet or anticoagulant agent, including: aspirin, clopidogrel, ticagrelor, prasugrel, warfarin, rivaroxaban, apixaban, edoxaban, dabigatran, etc.; * BARC stage 1 or 2; * Traditional Chinese Medicine pattern identified as phlegm-heat and blood stasis obstruction syndrome; * Age 18-90 years; * Signed informed consent. Exclusion Criteria: * Patients with gastrointestinal bleeding resulting in hemoglobin levels \<20 g/L and/or requiring hospitalization; * Gastrointestinal malignancies; * Cases where the source of occult blood cannot be distinguished, such as fresh bleeding from hemorrhoids; * Concurrent use of hemostatic traditional Chinese medicine preparations like Yunnan Baiyao; * Significant liver or kidney dysfunction, with ALT, AST, or serum creatinine exceeding three times the upper limit of normal; * Pregnant women, women planning pregnancy, or lactating women; * Individuals deemed unsuitable for this clinical trial by the investigator.